Vipan Datta

Norwich, ENG, GB 
Norwich, ENG, GB 

Overview

Vipan Datta practices practicing medicine in Norwich, United Kingdom.

Their clinical expertise encompasses Type 1 Diabetes (T1D), Melorheostosis, Arachnodactyly, and Achard Syndrome.

They are actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 2 clinical trials.

Locations

Norwich, ENG, United Kingdom
Other Locations
Guy's and St Thomas' NHS Foundation Trust
London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
Enrollment Status: Completed
Publish Date: July 20, 2025
Intervention Type: Drug
Study Drugs: MOD-4023, Somatropin
Study Phase: Phase 3
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: January 24, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Lispro
Study Phase: Phase 3
View 1 Less Clinical Trial

8 Total Publications

Successful use of a fully closed-loop insulin delivery system in an adolescent with diabetes secondary to pancreatitis - a case report.
Successful use of a fully closed-loop insulin delivery system in an adolescent with diabetes secondary to pancreatitis - a case report.
Journal: Annals of pediatric endocrinology & metabolism
Published: June 28, 2024

Frequently Asked Questions about Vipan Datta

Is Vipan Datta a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Vipan Datta is classified as an Experienced expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Vipan Datta participate in research or clinical trials?

Yes. Vipan Datta has published 8 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Vipan Datta's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Datta's expertise for a condition
ConditionClose
        View All 10 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile